{"title":"In vitro interaction between glabridin and voriconazole against Aspergillus fumigatus isolates","authors":"Mojtaba Nabili , Narges Aslani , Tahereh Shokohi , Mohammad Taghi Hedayati , Fozieh Hassanmoghadam , Maryam Moazeni","doi":"10.1016/j.riam.2020.12.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Voriconazole (VRC) is widely recommended as the first-line therapy for invasive aspergillosis. However, surveillance studies have demonstrated that there is an increase in the frequency of azole resistance among <em>Aspergillus fumigates</em> isolates. In recent years, more studies on effective synergisms between natural agents and antifungal drugs have been published.</p></div><div><h3>Aims</h3><p>To evaluate the synergistic antifungal effect of glabridin (Gla) and VRC against <em>A. fumigatus</em> isolates.</p></div><div><h3>Methods</h3><p>Potential interactions between Gla and VRC were studied by using a microdilution checkerboard method based on the CLSI reference technique. To assess the interaction of drugs the fractional inhibitory concentration index (FICI) was calculated based on the Loewe Additivity model.</p></div><div><h3>Results</h3><p>The minimum inhibitory concentrations (MIC) obtained with Gla alone were relatively high (MIC<sub>50</sub> 16<!--> <!-->μg/ml). However, our results showed synergistic interaction between Gla and VRC against <em>A. fumigatus</em><span> strains, with FICI range values between 0.15 and 0.5.</span></p></div><div><h3>Conclusions</h3><p>Synergistic activity of Gla and VRC against both VRC-sensitive and -resistant <em>A. fumigatus</em> isolates may lead to design new antifungal agents, especially for inhibiting those azole-resistant strains.</p></div>","PeriodicalId":21291,"journal":{"name":"Revista Iberoamericana De Micologia","volume":"38 3","pages":"Pages 145-147"},"PeriodicalIF":1.5000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.riam.2020.12.005","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Iberoamericana De Micologia","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1130140621000127","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 2
Abstract
Background
Voriconazole (VRC) is widely recommended as the first-line therapy for invasive aspergillosis. However, surveillance studies have demonstrated that there is an increase in the frequency of azole resistance among Aspergillus fumigates isolates. In recent years, more studies on effective synergisms between natural agents and antifungal drugs have been published.
Aims
To evaluate the synergistic antifungal effect of glabridin (Gla) and VRC against A. fumigatus isolates.
Methods
Potential interactions between Gla and VRC were studied by using a microdilution checkerboard method based on the CLSI reference technique. To assess the interaction of drugs the fractional inhibitory concentration index (FICI) was calculated based on the Loewe Additivity model.
Results
The minimum inhibitory concentrations (MIC) obtained with Gla alone were relatively high (MIC50 16 μg/ml). However, our results showed synergistic interaction between Gla and VRC against A. fumigatus strains, with FICI range values between 0.15 and 0.5.
Conclusions
Synergistic activity of Gla and VRC against both VRC-sensitive and -resistant A. fumigatus isolates may lead to design new antifungal agents, especially for inhibiting those azole-resistant strains.
期刊介绍:
Revista Iberoamericana de Micología (Ibero-American Journal of Mycology) is the official journal of the Asociación Española de Micología, Asociación Venezolana de Micología and Asociación Argentina de Micología (The Spanish, Venezuelan, and Argentinian Mycology Associations). The Journal gives priority to publishing articles on studies associated with fungi and their pathogenic action on humans and animals, as well as any scientific studies on any aspect of mycology. The Journal also publishes, in Spanish and in English, original articles, reviews, mycology forums, editorials, special articles, notes, and letters to the editor, that have previously gone through a scientific peer review process.